Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
04/2012
04/26/2012WO2012054425A2 Biodegradable particulate formulations
04/26/2012WO2012054376A2 Metal ion nanoclusters
04/26/2012WO2012054090A1 Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds
04/26/2012WO2012054029A1 Hair-mending compositions and associated methods
04/26/2012WO2012053942A1 Solutions for bicarbonate hemodialysis
04/26/2012WO2012053785A2 Sustained-release pellets containing tacrolimus as an active ingredient
04/26/2012WO2012053703A1 Composition for enteric hard capsules, and enteric hard capsule preparedusing the composition
04/26/2012WO2012053654A1 Sustained-release formulation for injection
04/26/2012WO2012053484A1 Process for production of uni-lamellar liposome by two-stage emulsification technique which involves adding water-soluble lipid to inner aqueous phase, and uni-lamellar liposome produced by the process
04/26/2012WO2012053016A1 Sustained release pharmaceutical compositions of donepezil
04/26/2012WO2012053014A2 Method for treatment of acne using pharmaceutical compositions of clindamycin and adapalene
04/26/2012WO2012053013A2 Pharmaceutical compositions of anti-acne agents
04/26/2012WO2012053012A2 Topical pharmaceutical compositions comprising tfflocolchicoside
04/26/2012WO2012053011A2 Ophthalmic compositions comprising brinzolamide
04/26/2012WO2012053010A2 Method for treatment of acne using pharmaceutical compositions of clindamycin
04/26/2012WO2012053008A1 Topical pharmaceutical compositions comprising etodolac
04/26/2012WO2012053007A1 Topical pharmaceutical compositions containing nanodroplets for the treatment psoriasis
04/26/2012WO2012053006A2 Improved oral fast dissolving films comprising combination of polymers and method of preparation thereof
04/26/2012WO2012052955A1 Process for making multiparticulate gastroretentive dosage forms
04/26/2012WO2012052918A1 Use of mexiprostil in the treatment of inflammatory bowel disease and/or of irritable bowel syndrome
04/26/2012WO2012052898A1 Lipid vectors delivering gene silencers
04/26/2012WO2012052834A2 Multiple unit particulate system comprising metoprolol succinate
04/26/2012WO2012052565A1 A polymeric nanoparticle
04/26/2012WO2012052561A2 Topical dermal delivery device for nitric oxide delivery
04/26/2012WO2012052527A1 Pendant hydrophile bearing biodegradable compositions and related devices
04/26/2012WO2012052479A2 Brimonidine gel compositions and methods of use
04/26/2012WO2012052478A2 Topical gel composition
04/26/2012WO2012052472A1 Pharmaceutical topical composition of mupirocin
04/26/2012WO2012052418A1 Liquid pharmaceutical composition for the delivery of active ingredients
04/26/2012WO2012052169A2 Particulate pharmaceutical composition containing an opioid and an opioid antagonist
04/26/2012WO2012051941A1 Uses of 15-benzylidene-14-deoxy-11,12-dehydroandrographolide derivatives in the preparation of antineoplastic drugs
04/26/2012WO2012032337A3 A transdermal drug administration device
04/26/2012WO2012030895A3 Hemostatic compositions and methods of making
04/26/2012WO2012029076A3 Stable pharmaceutical composition
04/26/2012WO2012024605A3 Devices and methods for intravaginal delivery of drugs and other substances
04/26/2012WO2012024405A3 Curcumin compositions and uses thereof
04/26/2012WO2012020301A3 Oral controlled release pharmaceutical compositions of blonanserin
04/26/2012WO2012018742A3 Dextromethorphan antitussive compositions
04/26/2012WO2012018240A3 Preparation of extremely small and uniform sized, iron oxide-based paramagnetic or pseudo-paramagnetic nanoparticles and mri t1 contrast agents using the same
04/26/2012WO2012017326A3 Apparatus and process for encapsulating capsules or other solid dosage forms within capsules
04/26/2012WO2012015789A3 Composition and method for the topicaltreatment of dermatitis
04/26/2012WO2011163206A4 Controlled release compositions with reduced food effect
04/26/2012WO2011156242A3 Improved anti-lysophospholipid antibody design using antibody structures
04/26/2012WO2011153513A3 Nanoemulsion composition containing vitamin k
04/26/2012WO2011141783A3 Pharmaceutical composition comprising irbesartan
04/26/2012WO2011135582A3 Pharmaceutical compositions of dronedarone
04/26/2012WO2011115969A3 Process of manufacturing a lyophilized fast dissolving, muti-phasic dosage form
04/26/2012WO2011110939A3 Pharmaceutical compositions of substituted benzhydrylpiperazines
04/26/2012WO2011107922A3 Extended release composition of milnacipran
04/26/2012WO2011074015A3 Composition of pharmaceutical product to treat sexual dysfunction
04/26/2012WO2011053252A1 Polymer coated magnetic particles
04/26/2012WO2011051354A4 Transdermal pharmaceutical compositions comprising active agents
04/26/2012WO2011012217A3 Co-precipitate comprising a phosphodiesterase-5 inhibitor (pde-5-inhibitor) and a pharmaceutically compatible carrier, production and use thereof
04/26/2012US20120101535 Bone repair putty
04/26/2012US20120101429 Sinus delivery of sustained release therapeutics
04/26/2012US20120101427 Novel photosensitizer formulations for oral administration
04/26/2012US20120101426 Method for Transdermal Delivery of Permeant Substances
04/26/2012US20120101055 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
04/26/2012US20120100278 Films for use as dosage forms
04/26/2012US20120100221 Pharmaceutical compositions containing a combination of an antihistamine and a decongestant
04/26/2012US20120100220 Drug composition for treating tumor with polymeric micelle encapsulating anti-neoplastic
04/26/2012US20120100219 Composition for the production of tablets, and method for the production of said composition
04/26/2012US20120100218 Intralymphatic Chemotherapy Drug Carriers
04/26/2012US20120100217 Polymeric material
04/26/2012US20120100216 Matrix carrier compositions, methods and uses
04/26/2012US20120100215 Muller stem cells
04/26/2012US20120100214 Sustained-Release Tablet and Process for Preparing the Same
04/26/2012US20120100213 Pharmaceutical formulations of a substituted diaminopurine
04/26/2012US20120100212 Tablet having hollow structure
04/26/2012US20120100211 Material and process for incorporation of low dosage active pharmaceutical ingredients and use thereof
04/26/2012US20120100210 Composition for the administration of polymeric drugs
04/26/2012US20120100209 Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride
04/26/2012US20120100208 Stable pharmaceutical composition and methods of using same
04/26/2012US20120100207 Process for producing liposomes by two-step emulsification method utilizing outer aqueous phase containing specific dispersing agent, process for producing liposome dispersion or dry powder thereof using the process for producing liposomes, and liposome dispersion or dry powder thereof produced thereby
04/26/2012US20120100206 Targeted liposomes comprising n-containing bisphosphonates and uses thereof
04/26/2012US20120100205 Components for producing amphoteric liposomes
04/26/2012US20120100204 TGF-Beta Stimulating Agent Compositions and Combinations
04/26/2012US20120100203 Fabrication of Biscrolled Fiber Using Carbon Nanotube Sheet
04/26/2012US20120100202 Manufacturing of small film strips
04/26/2012US20120100201 Thermally Stable, High Tensile Strength Encapsulated Actives
04/26/2012US20120100197 Novel esters, and use thereof
04/26/2012US20120100194 Chewing gum composition, chewing gum product, and method for manufacturing same
04/26/2012US20120100192 Local therapeutic release device
04/26/2012US20120100191 Methods and devices for delivery of pharmaceutical agents within orifices of the body
04/26/2012US20120100190 Controlled release sterile injectable aripiprazole formulation and method
04/26/2012US20120100189 Delayed release rasagiline malate formulation
04/26/2012US20120100188 Solid state forms of paliperidone salts and process for the preparation thereof
04/26/2012US20120100187 Coatings and methods for controlled elution of hydrophilic active agents
04/26/2012US20120100186 Nanoparticulate-based contraceptive/anti-hiv composition and methods
04/26/2012US20120100185 Regeneration of tissue without cell transplantation
04/26/2012US20120100184 Synthesis of 1-amino-1,3,3,5,5,-cyclohexane mesylate
04/26/2012US20120100183 Topical base and active agent-containing compositions, and methods for improving and treating skin
04/26/2012US20120100182 Continuous Cell Programming Devices
04/26/2012US20120100081 Composition and Method for Treating Wounds
04/26/2012US20120100080 Econazole Composition and Methods of Treatment Therewith
04/26/2012US20120100077 Mixture of amphipathic molecules and method for modifying cell membranes by means of fusion
04/26/2012US20120100068 Anti-CD74 Immunoconjugates and Methods of Use
04/26/2012US20120100067 Solubilisation Method
04/26/2012US20120097160 Agglomerate formulations including active pharmaceutical agents with targeted particle sizes
04/26/2012DE102010050457A1 Verbesserte pharmazeutische Starterpellets Improved pharmaceutical starter pellets
1 ... 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 ... 2991